SANDS CAPITAL MANAGEMENT, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Ultragenyx Pharmaceutical Inc. (RARE)

Filing Manager: SANDS CAPITAL MANAGEMENT, LLC
Reporting Manager: SANDS CAPITAL MANAGEMENT, LLC
Security: Ultragenyx Pharmaceutical Inc. Common Stock, par value $0.001 per share
Symbol: RARE
Shares outstanding: 91.4M shares
Disclosed Ownership: 4.3M shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Date filed: 2/12/2025, 11:42 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
SANDS CAPITAL MANAGEMENT, LLC	4.7%	4.3M	0	2.97M	/s/ Alexandra R. Fulk	Alexandra R. Fulk, Chief Compliance Officer, Senior Counsel
SANDS FRANK M.	4.7%	4.3M	0	2.97M	/s/ Frank M. Sands	Frank M. Sands